Page last updated: 2024-10-18

dalteparin and Premature Rupture of Fetal Membranes

dalteparin has been researched along with Premature Rupture of Fetal Membranes in 3 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"Subchorionic hematoma is a potentially serious complication that can occur in pregnant patients receiving enoxaparin for the prevention of thromboembolism."1.33Massive subchorionic hematoma associated with enoxaparin. ( Goodwin, TM; Lee, RH, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martí-Gamboa, S1
Savirón Cornudella, R1
Campillos-Maza, JM1
Lee, RH1
Goodwin, TM1
Stone, S1
Hunt, BJ1
Seed, PT1
Parmar, K1
Khamashta, MA1
Poston, L1

Reviews

1 review available for dalteparin and Premature Rupture of Fetal Membranes

ArticleYear
[Massive gestational vulvar edema. A case report and review of literature].
    Ginecologia y obstetricia de Mexico, 2014, Volume: 82, Issue:9

    Topics: Albumins; Anti-Infective Agents; Anticoagulants; Cesarean Section; Edema; Enoxaparin; Exudates and T

2014

Other Studies

2 other studies available for dalteparin and Premature Rupture of Fetal Membranes

ArticleYear
Massive subchorionic hematoma associated with enoxaparin.
    Obstetrics and gynecology, 2006, Volume: 108, Issue:3 Pt 2

    Topics: Adult; Anticoagulants; Atrial Fibrillation; Cesarean Section; Chorion; Enoxaparin; Factor Xa Inhibit

2006
Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy.
    American journal of obstetrics and gynecology, 2003, Volume: 188, Issue:2

    Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Dalteparin; Endothelium, Vascular; F

2003